Dr. Muhammad A. Ehtesham, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 680
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
MI license 4301072332 -
Critical Care Medicine (Internal Medicine) Physician
MI license 4301072332
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ascension Providence Hospital, Southfield and Novi Southfield, MI
- Trinity Health Livingston Hospital Howell, MI
Medical groups
- Consultants in Sleep and Pulmonary Medicine PLLC (14 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 680
- Services billed
- 1,507
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 251 | 209 |
| Critical care, first 30-74 minutes | 244 | 145 |
| Established patient office or other outpatient visit, 30-39 minutes | 241 | 169 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 153 | 114 |
| Test to determine lung volumes using sensors | 68 | 66 |
| Test to examine how well the lungs exchange gases | 68 | 66 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 57 | 46 |
| New patient office or other outpatient visit, 45-59 minutes | 57 | 57 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 48 | 47 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 40 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Farmington Hills, MI | 465 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Farmington Hills, MI | 315 |
| Prednisone Other prescribers in Farmington Hills, MI | 235 |
| Montelukast Sodium Other prescribers in Farmington Hills, MI | 211 |
| Azithromycin Other prescribers in Farmington Hills, MI | 194 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Farmington Hills, MI | 101 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Farmington Hills, MI | 81 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Farmington Hills, MI | 75 |
| Fluticasone Propionate Other prescribers in Farmington Hills, MI | 70 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Farmington Hills, MI | 65 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 144 payments worth $10,221 in total to this clinician.
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,738 |
|---|---|
| GlaxoSmithKline, LLC. | $684 |
| Genzyme Corporation | $422 |
| AstraZeneca Pharmaceuticals LP | $243 |
| Regeneron Healthcare Solutions, Inc. | $193 |
| Insmed, Inc. | $185 |
| United Therapeutics Corporation | $158 |
| Mallinckrodt Hospital Products Inc. | $77.73 |
| Consulting Fee | $4,669 |
|---|---|
| Food and Beverage | $2,807 |
| Travel and Lodging | $2,709 |
| Education | $36.82 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. May 8, 2025 | Consulting Fee | $4,669 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $793 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $793 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 31, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $293 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 31, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $293 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 8, 2025 | Travel and Lodging travel to Tampa, FL · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $58.52 |
| Amgen Inc. Sep 16, 2025 | Education in-kind | $34.00 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Sep 16, 2025 | Education in-kind | $34.00 |
| Regeneron Healthcare Solutions, Inc. May 14, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $2.82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 8, 2025 | Consulting Fee | $4,669 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 8, 2025 | Travel and Lodging travel to Tampa, FL · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $58.52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $793 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 4, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $793 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 31, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $293 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 31, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Tampa, FL · in-kind | $293 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.